权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins

小分子环调节蛋白的鉴定、功能分析和生物合成的化学方法

基本信息

批准号：
10296659
负责人：
Steven D Bruner
金额：
$ 57.34万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-12-11 至 2023-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10296659
关键词：
Address Anabolism Animals Apoptosis Azoxymethane Bacteria Bacterial Toxins Biological Assay Biomimetics Carbamates Cell Cycle Cell Cycle Progression Chemicals Chemistry Colitis Colorectal Cancer Complex Crystallography Cyclization Cytotoxin DNA DNA Alkylation DNA Damage DNA Double Strand Break Data Disease Embryo Employment Enzymatic Biochemistry Enzymes Epidemiology Escherichia coli Eukaryotic Cell Europe Evaluation Exposure to Felis catus Gastrointestinal Diseases Gene Cluster Genetic Goals Grant Human Imines In Vitro Light Literature Mammalian Cell Mediating Methods Modeling Molecular Mus Natural Products Nucleotides Orphan Pathway interactions Peptide Hydrolases Phenocopy Phenotype Physiology Pre-Clinical Model Probiotics Prodrugs Production Proteins Pyridones Reaction Research Research Personnel Resistance Role Route Side Signal Transduction Structure Testing Tin Work X-Ray Crystallography Zebrafish carcinogenesis chemical synthesis cyclopropane cytotoxic deacylation feeding genotoxicity in vivo insight microbiota novel therapeutic intervention oxazolidine oxidation preclinical study response skeletal small molecule symbiont tissue culture treatment response tumor tumorigenesis tumorigenic

项目摘要

PROJECT SUMMARY/ABSTRACT. Bacteria on and within the body (the microbiota) influence human physiology, therapeutic responses, and disease states. Cyclomodulins are bacterial toxins and effectors that modulate eukaryotic cell cycle progression, proliferation, differentiation, or apoptosis, and may be genotoxic. Certain strains of E. coli in the human gut contain a gene cluster (referred to as “clb”) that encodes small molecule cyclomodulins known as precolibactins. Evidence suggests precolibactins are prodrugs that are converted to cytotoxins (colibactins) by a dedicated peptidase (colibactin peptidase, ClbP). clb+ E. coli induce DNA double-strand breaks in mammalian cells in vitro and in vivo, suggesting these molecules are trafficked (by an unknown mechanism) to eukaryotic cells, and initiate tumor formation in colitis-susceptible mice treated with azoxymethane. Several independent studies have demonstrated that the clb cluster is epidemiologically correlated with colorectal cancer in humans. As colibactins are unstable, all isolation efforts have employed clbP deletion strains to facilitate accumulation of the more stable precolibactins. We developed convergent high-yielding syntheses of linear precolibactin biosynthetic precursors and showed they transform to unsaturated imines after ClbP deacylation; these imines alkylate DNA by nucleotide addition to an electrophilic cyclopropane. Structure–function studies established distinct DNA recognition and prodrug domains. Of equal significance, our data indicate that the use of clbP deletion strains results in the production of alternative, non-genotoxic structures, such as precolibactins A–C. Precolibactin-886 is the most complex clb isolate known and is the first that contains an α-aminomalonate residue, which is believed to be important for cytopathic effects. We hypothesize that the unusual macrocyclic structure of precolibactin-886 also derives from employment of a clbP deletion strain. To test this we will prepare precolibactin-886 and key synthetic derivatives/biosynthetic precursors and elucidate their chemistry. We will determine if deacylation of the linear precursor to precolibactin-886 leads to production of similar electrophilic imines. We will evaluate the potency, cell cycle effects, and DNA-damaging abilities of synthetic colibactins and controls in a zebrafish model. Using enzymology, genetic deletion studies, and X-ray crystallography, we will elucidate the roles of the enzymes ClbL, ClbO, ClbM and ClbS, which are encoded in the clb cluster but do not have well-defined functional roles. The latter two enzymes phenotypically contribute to colibactin resistance and their study may illuminate methods to inhibit clb+ E. coli-associated colorectal cancer. This grant employs four investigators with non-overlapping expertise in chemical synthesis, natural products biosynthesis and isolation, preclinical studies of clb+ E. coli in vitro and in vivo, and enzymology and protein crystallography. This work will establish a mechanistic model that accounts for all known precolibactins, define the molecular mechanisms by which certain E. coli induce carcinogenesis, and inform strategies to inhibit clb+ E. coli-driven tumorigenesis. These studies will provide insights into the functional roles of non-proteiogenic cyclomodulins.

项目总结/抽象。